Open Philanthropy recommended a gift of $2,500,000 to Stanford University to support research led by Professor Jeffrey Glenn on the development of a treatment to cure chronic hepatitis B virus (HBV) infections and prevent HBV-induced liver cancer. Existing drugs treat, but do not cure, the disease. Over 300 million people globally have chronic HBV, many of whom develop fatal liver cancer.
This follows Open Philanthropy’s May 2020 support and falls within its work on scientific research, specifically within its interest in advancing human health and wellbeing.